2026-08-12 DoubleBlind Magazine

The Toads Didn’t Consent to Being Milked, Sorry

Chasing "enlightenment" at the expense of desert toads is not the flex you think it is. [...] Read More... The post The Toads Didn’t Consent to Being Milked, Sorry appeared first on DoubleBlind Mag.

External link. We are not responsible for the content.

Read more ↗

More From DoubleBlind Magazine

2026-08-10 DoubleBlind Magazine

Could Ayahuasca Help Minimize the Loneliness Epidemic?

PLUS, ketamine clinics in Beirut, the Horizons conference, and trip-free psychedelics. [...] Read More... The post Co...

2026-08-07 DoubleBlind Magazine

Inside the Arab World’s Psychedelic Revival

How four countries are reshaping psychedelic therapy in the SWANA region. [...] Read More... The post Inside the Arab...

2026-08-05 DoubleBlind Magazine

A Psychedelic Crime Novel Exploring What Nonfiction Can’t Reach

Lindsay Kent's psychedelic novel is an argument for fiction as a way of arriving at truth. [...] Read More... The pos...

Latest News

2026-08-11 Microdose (industry)

Psychedelic Medicine Is Having an Identity Crisis — And That’s a Good Thing

For most of the last decade, the story of psychedelic medicine was a story about the trip itself. Guided sessions. Ey...

2026-08-11 Microdose (industry)

Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won’t Get You High

Enveric Biosciences is trying to answer one of the trickiest questions in the psychedelic drug space: can you get the...

Research
2026-08-11 Psychedelics Today

Weekly Psychedelic Policy Briefing – August 9, 2026

Jack Gorsline, investigative journalist, covers four federal developments this week. The Department of Veterans Affai...

2026-08-10 MAPS

MAPS Responds to Report of Progress for MDMA-assisted therapy for PTSD with FDA

August 10, 2026 — The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) today responded to an A...

2026-08-10 The Microdose (Berkeley)

Why don’t some people respond to psychedelics? 5 Questions for psychologist Rachel Ham

Ham discusses doing interviews with clinical trial participants who didn’t experience substantial benefits.

2026-08-10 Psychedelics Today

Ibogaine’s Moment Has Arrived. Are We Ready to Meet It?

MAPS co-executive director Ismail Lourido Ali on what the April 2026 executive order, the Texas and Colorado funding ...